× ABOUT THEFLAG®
PRODUCTS
THEAGE® THEBRAIN® THEDRY® THEHEAD® THEMOVE® THESHAPE®

Exclusively designed
to help improve
urinary function

icon-perla
icon-perla
icon-flecha
icon-flecha

THEDRY ®

We have created a unique product exclusively designed for women’s health based on clinical trials* that demonstrate the exclusive formula of THEDRY® offers:

icon dry

Visible results from
4 weeks

icon dry

A better quality of
life for 92% of women

icon dry

More than 96%
of women
satisfied

dry-prod01 dry-prod01

2 out of 5 women experience
urinary incontinence at
some point in their lives

This can affect our day to day lives, altering our lifestyle as well as our social relationships.

Urinary incontinence can increase with age in women who have given birth and during menopause, conditioning hygiene and reducing well-being.

Study results in women with mild/moderate incontinence* demonstrate that THEDRY®:

  • Can help reduce the use of pads by more than 66%.
  • Contributes to a reduction in nighttime urine loss by more than 69%, improving sleep quality.
  • 92% of women state having experienced a notable improvement in their quality of life.
  • More than 96% of women are satisfied with THEDRY®.
icon-01

Results from 4 weeks

dry-prod02 dry-prod02

Clinical trials* have shown that soy, with a high content of genistein (SOLGEN®) and polyphenols such as pyrogallol and enterodiol from pumpkin extract (CUCURBIDIOL®), present in THEDRY®, contribute to maintaining the elasticity of the bladder wall and the strength of the pelvic floor.

  • Take 1 tablet a day during breakfast.

THEDRY® is an exclusive product with a unique formulation enhanced with DROPSORDRY® from soy isoflavones, with a high concentration of Genistein (SOLGEN®) and pumpkin extract (CUCURBIDIOL®).

Each tablet of THEDRY® contains 500 mg of DROPSORDRY® with:

  • 410 mg of CUCURBIDIOL®.
  • 90 mg of SOLGEN®.
icon-1
GLUTEN-FREE
icon-2
LACTOSE-FREE
icon-3
CAFFEINE-FREE
icon-4
SUGAR-FREE

Bell R, et al. Ann Intern Med. 2018;169(5):345-6.
Gómez A. Offarm. 2008;27(3):60-71.
Marañón JA, et al. ICOG 2016; 25 & 26 February; London, United Kingdom 2016.
Marañón JA, et al. 24th EBCOG; 19 - 21 May; Torino, Italy 2016.
Marañón JA, et al. J Gynecol Women’s Health. 2017;4(1):1-4*
Turgut A, et al. Acta Medica Mediterr. 2014;30(4):10.
Vila M, et al. SEMERGEN. 2005;31(6):270-83.

Recommended products

icon-flecha
icon-perla